These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21390017)

  • 21. Biotechs follow big pharma lead back into academia.
    Kling J
    Nat Biotechnol; 2011 Jul; 29(7):555-6. PubMed ID: 21747364
    [No Abstract]   [Full Text] [Related]  

  • 22. Millennium ends Takeda's US shopping spree.
    Sipp D
    Nat Biotechnol; 2008 Jun; 26(6):593-5. PubMed ID: 18536661
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmaceutical futures: made in China?
    Cyranoski D
    Nature; 2008 Oct; 455(7217):1168-70. PubMed ID: 18971994
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiinfective biotechs face partnering gap.
    Sheridan C
    Nat Biotechnol; 2005 Feb; 23(2):155-6. PubMed ID: 15696131
    [No Abstract]   [Full Text] [Related]  

  • 25. Elias Zerhouni.
    Zerhouni E
    Nat Biotechnol; 2011 Mar; 29(3):188. PubMed ID: 21390007
    [No Abstract]   [Full Text] [Related]  

  • 26. Earlier stage biotechs attract partners.
    Ratner M
    Nat Biotechnol; 2005 May; 23(5):509. PubMed ID: 15877052
    [No Abstract]   [Full Text] [Related]  

  • 27. Anthony Coyle.
    Coyle A
    Nat Biotechnol; 2011 Mar; 29(3):187. PubMed ID: 21390006
    [No Abstract]   [Full Text] [Related]  

  • 28. Does biotech M&A benefit investors?
    Jacobs T
    Nat Biotechnol; 2004 Sep; 22(9):1085. PubMed ID: 15340472
    [No Abstract]   [Full Text] [Related]  

  • 29. Study critiques corporate control of trials.
    Niiler E
    Nat Biotechnol; 2002 Dec; 20(12):1180. PubMed ID: 12454659
    [No Abstract]   [Full Text] [Related]  

  • 30. UK biotech sector loses flagship PowderJect to Chiron.
    Mitchell P
    Nat Biotechnol; 2003 Jul; 21(7):717. PubMed ID: 12833073
    [No Abstract]   [Full Text] [Related]  

  • 31. Dynogen's SPAC.
    Osborne R
    Nat Biotechnol; 2008 Apr; 26(4):360. PubMed ID: 18391998
    [No Abstract]   [Full Text] [Related]  

  • 32. Contract manufacturers add contract design to their services.
    Resnick E
    Med Device Technol; 2007; 18(7):38-9. PubMed ID: 18075134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outsourcing for product success and restful nights.
    Hale D
    Med Device Technol; 2008; 19(7):32, 34-5. PubMed ID: 19133626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biopharma CRO industry in China: landscape and opportunities.
    Xia C; Gautam A
    Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ask George.
    Mills G
    Biomed Instrum Technol; 2016; 50(1):11. PubMed ID: 26829134
    [No Abstract]   [Full Text] [Related]  

  • 36. The seven deadly sins of business development.
    Stewart JJ; Bonifant B
    Nat Biotechnol; 2008 Apr; 26(4):375-7. PubMed ID: 18404814
    [No Abstract]   [Full Text] [Related]  

  • 37. Syngenta rebuffs Monsanto, again.
    Nat Biotechnol; 2015 Oct; 33(10):1014. PubMed ID: 26448074
    [No Abstract]   [Full Text] [Related]  

  • 38. Virtual recruitment.
    Mills E
    Nat Biotechnol; 2002 Aug; 20(8):853. PubMed ID: 12148015
    [No Abstract]   [Full Text] [Related]  

  • 39. BEAM to fight antimicrobial resistance.
    Nat Biotechnol; 2015 Sep; 33(9):889. PubMed ID: 26348940
    [No Abstract]   [Full Text] [Related]  

  • 40. Indian biotechs partner with government.
    Jayaraman KS
    Nat Biotechnol; 2009 Apr; 27(4):305. PubMed ID: 19352355
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.